Orthobiologics Market
Growth Factors of Orthobiologics Market
The orthobiologics market size was valued at USD 8.77 billion in 2023, and the market is now projected to grow from 9.22 billion in 2024 to USD 14.42 billion by 2032, exhibiting a CAGR of 5.7% during the forecast period of 2024-2032.
COVID 19 affected orthobiologics market worldwide affecting supply chain and Elective surgeries caused by lock down measures. Due to the COVID-19 breakout, many hospitals shifted their focus to treat COVID patients and a large number of elective surgeries including orthopaedic, orthobiologics got delayed, thus reducing the market of orthobiologics products. However, there has been a boost in the sector after the COVID increased concentration on the recovery of the patients after admissions. Further, growth in the healthcare technology front such as telemedicine and remote patient monitoring during covid has paved way for orthobiologics to come up with new ideas and innovations when adapting to the new future.
The orthobiologics market has experienced few key characteristics; some of the advancements include regenerative medicine procedures like stem cell therapy and platelet-rich plasma (PRP) therapy. High demands for minimally invasive surgery have lead to the creation of new delivery methods for orthobiologics. Not only has specialization in biomaterials improved the effectiveness of treatments, but this knowledge leads to better outcomes. While technology like 3D printing and the application of artificial intelligence is also influencing the form of product design and custom treatment options. In order to sum, these trends depict better patient centric approach and improved recovery solutions. Thus, all the above mentioned factors are contributing towards the veterinary diagnostics market growth.
There are several market drivers contributing to the growth of orthobiologics market today these include increased incidence of musculoskeletal disorder, increased population and advances in technology. Progress made in the use of stem cells, tissue engineering and other applications improve the prospects for development of orthobiologics. Furthermore, increasing demand for minimally invasive products by patients and physicians experience is also driving the market. Higher levels of research and development spending by global pharmaceuticals and biotechnology industries are also enhancing the pace of innovation in this segment, and the subsequent launch of value-added products and therapies.
Comprehensive Analysis Orthobiologics Market
For segmentation purpose, the orthobiologics market has been divided based on product type, application and end use. Some of the most important products are: joint therapies such as visco-supplements that down regulates joint pain; growth factors for bone healing; DBM; synthetic bone grafts; and cellular allograft for instance. In terms of applications, it operates in spinal fusion, maxillo facial / dental, soft tissue repair, reconstructive/ fracture surgeries and many others. The targets are hospitals and ambulatory surgical centers (ASCs), reprocessing specialty clinics, and other user facilities that demonstrate a wide range of orthobiologics applications to multiple patient populations.
North America has the strongest market for orthobiologics due to social factors such as; well-developed health system, high health care costs and increasing frail of geriatric population who are prone to orthobiologics requirement diseases. The region has excellent R&D investments to support growth in regenerative medicine and orthobiologics products. Moreover, the strong growth of key market players, trump card medical facilities raises the acceptance levels of new technological treatments. Sports injuries are more and more common and there is a higher demand for using orthobiologics as an endovenous treatment which also explain why North America leads the orthobiologics market in the world.
Key players in this sector include Medtronic (Ireland), Zimmer Biomet (U.S.), DePuy Synthes (Johnson & Johnson Services, Inc.) (U.S.), Stryker (U.S.), Anika Therapeutics, Inc. (U.S.), SeaSpine (U.S.), Bioventus (U.S.), RTI Surgical (U.S.), MTF Biologics (U.S.)
One of the most observed trends in the orthobiologics market in 2023 is an increased utilization of various highly-developed cellular therapies with Particular Focus on Stem Cells. The use of these therapies in furthering recovery in orthopedic operations is gradually gaining acceptance. Business are paying attention on creation of products containing adipose-derived stem cells and bone marrow aspirate for better regenerative results in conditions linked with osteoarthritis and tendon disorders. This transition to molecular biology based medicine as a result of developing bio-processing and cellular technologies is however an indication of an increasing focus on the use of more efficient treatment protocols in orthobiologics.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 5.7% from 2024-2032
Unit Value (USD billion)
Segmentation
By Product Type
Viscosupplements
Bone Growth Factors
Demineralized Bone Matrix (DBM)
Synthetic Bone Substitutes
Cellular Allograft
Others
By Application
Spinal Fusion
Maxillofacial & Dental
Soft Tissue Repair
Reconstructive & Fracture Surgery
Others
By End-user
Hospitals & ASCs
Specialty Clinics
Others
By Geography
North America (By Product Type, By Application, By End-user, and By Country)
- U.S. (By Application)
- Canada (By Application)
- Germany (By Application)
- U.K. (By Application)
- France (By Application)
- Italy (By Application)
- Scandinavia (By Application)
- Rest of Europe (By Application)
- China (By Application)
- India (By Application
- Japan (By Application)
- Australia (By Application)
- Southeast Asia (By Application)
- Rest of Asia Pacific (By Application)
- Brazil (By Application)
- Mexico (By Application)
- Rest of Latin America (By Application)
- South Africa (By Application)
- GCC (By Application)
- Rest of Middle East & Africa (By Application)
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Epidemiology of Clinical Indications
- 4.2. Regulatory Scenario for Key Countries
- 4.3. New Product Launches
- 4.4. Key Industry Developments (Mergers, Acquisitions, and Partnership)
- 4.5. Impact of COVID-19 on the Market
- 5. Global Orthobiologics Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Product Type
- 5.1.1. Viscosupplements
- 5.1.2. Bone Growth Factors
- 5.1.3. Demineralized Bone Matrix (DBM)
- 5.1.4. Synthetic Bone Substitutes
- 5.1.5. Cellular Allograft
- 5.1.6. Allografts
- 5.1.7. Others
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Spinal Fusion
- 5.2.2. Maxillofacial & Dental
- 5.2.3. Soft Tissue Repair
- 5.2.4. Reconstructive & Fracture Surgery
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast – By End-user
- 5.3.1. Hospitals & ASCs
- 5.3.2. Specialty Clinics
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Orthobiologics Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Product Type
- 6.1.1. Viscosupplements
- 6.1.2. Bone Growth Factors
- 6.1.3. Demineralized Bone Matrix (DBM)
- 6.1.4. Synthetic Bone Substitutes
- 6.1.5. Cellular Allograft
- 6.1.6. Allografts
- 6.1.7. Others
- 6.2. Market Analysis, Insights and Forecast – By Application
- 6.2.1. Spinal Fusion
- 6.2.2. Maxillofacial & Dental
- 6.2.3. Soft Tissue Repair
- 6.2.4. Reconstructive & Fracture Surgery
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast – By End-user
- 6.3.1. Hospitals & ASCs
- 6.3.2. Specialty Clinics
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.1.1. By Application
- 6.4.2. Canada
- 6.4.2.1. By Application
- 7. Europe Orthobiologics Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Product Type
- 7.1.1. Viscosupplements
- 7.1.2. Bone Growth Factors
- 7.1.3. Demineralized Bone Matrix (DBM)
- 7.1.4. Synthetic Bone Substitutes
- 7.1.5. Cellular Allograft
- 7.1.6. Allografts
- 7.1.7. Others
- 7.2. Market Analysis, Insights and Forecast – By Application
- 7.2.1. Spinal Fusion
- 7.2.2. Maxillofacial & Dental
- 7.2.3. Soft Tissue Repair
- 7.2.4. Reconstructive & Fracture Surgery
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast – By End-user
- 7.3.1. Hospitals & ASCs
- 7.3.2. Specialty Clinics
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 7.4.1. Germany
- 7.4.1.1. By Application
- 7.4.2. U.K.
- 7.4.2.1. By Application
- 7.4.3. France
- 7.4.3.1. By Application
- 7.4.4. Italy
- 7.4.4.1. By Application
- 7.4.5. Spain
- 7.4.5.1. By Application
- 7.4.6. Scandinavia
- 7.4.6.1. By Application
- 7.4.7. Rest of Europe
- 7.4.7.1. By Application
- 8. Asia Pacific Orthobiologics Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Product Type
- 8.1.1. Viscosupplements
- 8.1.2. Bone Growth Factors
- 8.1.3. Demineralized Bone Matrix (DBM)
- 8.1.4. Synthetic Bone Substitutes
- 8.1.5. Cellular Allograft
- 8.1.6. Allografts
- 8.1.7. Others
- 8.2. Market Analysis, Insights and Forecast – By Application
- 8.2.1. Spinal Fusion
- 8.2.2. Maxillofacial & Dental
- 8.2.3. Soft Tissue Repair
- 8.2.4. Reconstructive & Fracture Surgery
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast – By End-user
- 8.3.1. Hospitals & ASCs
- 8.3.2. Specialty Clinics
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 8.4.1. China
- 8.4.1.1. By Application
- 8.4.2. India
- 8.4.2.1. By Application
- 8.4.3. Japan
- 8.4.3.1. By Application
- 8.4.4. Australia
- 8.4.4.1. By Application
- 8.4.5. Southeast Asia
- 8.4.5.1. By Application
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Application
- 9. Latin America Orthobiologics Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Product Type
- 9.1.1. Viscosupplements
- 9.1.2. Bone Growth Factors
- 9.1.3. Demineralized Bone Matrix (DBM)
- 9.1.4. Synthetic Bone Substitutes
- 9.1.5. Cellular Allograft
- 9.1.6. Allografts
- 9.1.7. Others
- 9.2. Market Analysis, Insights and Forecast – By Application
- 9.2.1. Spinal Fusion
- 9.2.2. Maxillofacial & Dental
- 9.2.3. Soft Tissue Repair
- 9.2.4. Reconstructive & Fracture Surgery
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast – By End-user
- 9.3.1. Hospitals & ASCs
- 9.3.2. Specialty Clinics
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Application
- 9.4.2. Mexico
- 9.4.2.1. By Application
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Application
- 10. Middle East & Africa Orthobiologics Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast – By Product Type
- 10.1.1. Viscosupplements
- 10.1.2. Bone Growth Factors
- 10.1.3. Demineralized Bone Matrix (DBM)
- 10.1.4. Synthetic Bone Substitutes
- 10.1.5. Cellular Allograft
- 10.1.6. Allografts
- 10.1.7. Others
- 10.2. Market Analysis, Insights and Forecast – By Application
- 10.2.1. Spinal Fusion
- 10.2.2. Maxillofacial & Dental
- 10.2.3. Soft Tissue Repair
- 10.2.4. Reconstructive & Fracture Surgery
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast – By End-user
- 10.3.1. Hospitals & ASCs
- 10.3.2. Specialty Clinics
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 10.4.1. South Africa
- 10.4.1.1. By Application
- 10.4.2. GCC
- 10.4.2.1. By Application
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Application
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2023)
- 11.2. Company Profiles
- 11.2.1. Medtronic
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Zimmer Biomet
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.)
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Stryker
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Anika Therapeutics, Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. SeaSpine
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Bioventus
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. RTI Surgical
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. MTF Biologics
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Arthrex, Inc.
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
- 11.2.11. Smith & Nephew
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Strategies
- 11.2.11.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook